Journal of Pharmacy and Pharmaceutics

ISSN: 2377-1313 Impact Factor: 0.676
Editor In Cheif
Andrew Allen Webster (Editor-in-Chief)

Editor In Chief

About Journal

Journal of Pharmacy & Pharmaceutics is an open access journal that aims to publish research, reviews, mini-reviews, short communications and editorials dealing with all branches of Pharmaceutics. It is a peer-reviewed journal that encircles various branches of Pharmacy research which includes pharmaceutical analysis, medicinal chemistry, pharmacology, drug discovery, drug design, formulation of dosage forms, bioavailability & bioequivalence studies, clinical pharmacy, animal toxicity studies, clinical trials for testing safety & efficacy of drug products, drug products specifications, quality control & quality assurance, quality by design, regulatory approval and quality risk management etc., in the field of pharmaceutics. Journal of Pharmacy & Pharmaceutics publishes papers of high quality in all areas of Pharmacy related fields.

JPP encourages researchers to submit their valuable manuscripts for rapid publication and also invites editors and reviewers to join editorial team all around the world. JPP hopes that Researchers, Research scholars, Academician, etc. would make use of this journal publication for the development of science and technology.


Aim & Scope

Journal of Pharmacy & Pharmaceutics is developed as an internationally peer reviewed journal to provide an unrestricted access in the fields of pharmacy and pharmaceutics. The title of the journal changed from Journal of Pharmaceutical Science and Drug Designing to Journal of Pharmacy & Pharmaceutics. Leading articles, meeting reports, critical commentaries, letters, and book reviews  dealing with pharmaceutical  sciences (Pharmacy, Pharmacognosy, Pharmaceutics, Pharmacokinetics, Pharmaceutical Analysis, Pharmacy Practice) etc are accepted.

Journal of Pharmacy & Pharmaceutics follows the Creative Commons Attribution License and scholars open access publishing policies, readers can freely access the published articles through online with unique Digital Objective Identifier (DOI) provided by Cross Ref.





1. Pharmacokinetics 2. Pharmacodynamics 3. Clinical Pharmacy 4. Industrial Pharmacy 5. Pharmaceutical practices 6. Novel Drug Discovery 7. Experimental Pharmacostudies 8. Protein Remodelling Drug Discovery 9. Pharmacovigulence 10. Medicinal Chemistry 11. Drug Chemistry 12. Screening of New Drugs 13. Pharmaceutical Formulation 14. Therapeutic Drugs 15. Pharmaceutical Technologies 16. Drug Trageting 17. Pharmacogenomics 18. Pharmacoproteomics 19. Drug Safety 20. Regenerative Medicine 21. Pharmacoepidemiology 22. Drug Delivery 23. Pharmacognosy 24. Pharmaceutical Analysis 25. Drugs from Natural Resource Drug Disposition

Publication Charges

Ommega Publishers sincerely believes and charges reasonably in other words it is one of the publishers that provides a platform which charges economically towards the publication charges so that there are no barriers for free and fruitful knowledge sharing. Ommega Publishers have also classified their charges as defined by the World Bank Country Classification table: High Income countries, Middle Income countries and Low Income countries

Ommega journals are Open Access and do not receive any funding, we solely depend on Authors through membership fees, and article processing charges to meet the expenses like managing the team of Editorial experts and professionals to advance and support needs arising in the fields of editorials boards,marketing and IT, peer reviewing of the articles,editing of articles, developing and maintaining the software and information technology, updating the journal website, archiving of the articles and other costs associated concerning to maintain global standards of Publishing.

Ommega publishers believes and maintains high quality of services and articles through this model each and every manuscript that is accepted attract publication charges.Ommega publishers does not support any hidden costs, charge for color figures,as well as does not charge any additional fees for all the authors worldwide.

If for some reason, Researcher/ Author is unable to pay the processing charges, they can submit their applications citing the reasons for a waiver or discount to before or immediately after submitting their article.

Waivers are calculated on the Article processing fees of the related Journal after the submission and acceptance of the manuscript.

"Article Publishing Charges"charged by Ommega Online Publishers for publishing manuscripts are as follows.

Country Fee Description
SC/MR/CR/letters RA
High Income 569 USD 792 USD
Middle Income 470 USD 569 USD
Low Income 225 USD 445 USD

SC=Short communication
MR=Mini review
CR= Case report
RA = Review Article/ Research Article
Note:The prices and guidelines mentioned above are subject to change without prior notice.


Pharmacokinetics, Pharmacodynamics, Clinical Pharmacy, Industrial Pharmacy, Pharmaceutical practices, Novel Drug Discovery, Experimental Pharmacostudies, Medicinal Chemistry, Drug Chemistry, Pharmaceutical Formulation, Therapeutic Drugs, Pharmaceutical Technologies, Drug Trageting, Pharmacogenomics, Pharmacoproteomics, Drug Safety, Regenerative , Medicine, Pharmacoepidemiology, Drug Delivery, Pharmacognosy, Pharmaceutical Analysis, Drugs from Natural Resource, Drug Disposition